癌症對通過PD-1阻斷實現的免疫療法響應的決定因素
- 专利权人:
- Memorial Sloan Kettering Cancer Center
- 发明人:
- CHAN, Timothy A.,RIZVI, Naiyer A.,HELLMAN, Matthew D.
- 申请号:
- HK18103939.8
- 公开号:
- HK1244440A
- 申请日:
- 2018.03.21
- 申请国别(地区):
- HK
- 年份:
- 2018
- 代理人:
- 摘要:
- Molecular determinants of cancer response to immunotherapy are described, as are systems and tools for identifying and/or characterizing cancers likely to respond to immunotherapy.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- DETERMINANTS OF CANCER RESPONSE TO IMMUNOTHERAPY
- DETERMINANTS OF CANCER RESPONSE TO IMMUNOTHERAPY BY PD-1 BLOCKADE
- DETERMINANTS OF CANCER RESPONSE TO IMMUNOTHERAPY BY PD-1 BLOCKADE
- Determinants of cancer response to immunotherapy by PD-1 blockade
- DÉTERMINANTS DE LA RÉPONSE D'UN CANCER À UNE IMMUNOTHÉRAPIE PAR BLOCAGE DE PD-1